Literature DB >> 30567237

Difficult case of a rare form of familial Alzheimer's disease with PSEN1 P117L mutation.

Ana Luísa Rocha1, Andreia Costa1, Maria Carolina Garrett1, Joana Meireles2.   

Abstract

Less than 10% of Alzheimer's disease (AD) cases are familial. Presenilin-1 (PSEN1) mutations are the most frequent aetiology and may be associated to atypical neurological manifestations. We report the case of a 27-year-old right-handed man, ensuing with mild cognitive impairment, motor discoordination and axial myoclonus after a parachute accident. At age 32 he was referred to our neurology clinic, presenting cognitive impairment, cerebellar syndrome, axial myoclonus and hypomimia, without other signs of parkinsonism. Because of absence of family history, he was worked up along the line of spinal ataxic disorders. Later, he developed pseudobulbar affect, cognitive deterioration, right upper limb paresis and spastic paraparesis. Subsequent investigation identified a PSEN1 P117L mutation and the diagnosis of autosomal dominant AD was made. This case illustrates the diagnostic challenge imposed by atypical presentation of de novo PSEN1 mutation, leading to unnecessary investigation. Genetic study might be essential for defining the diagnosis. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dementia, Alzheimer’s type; memory disorders; neuro genetics; neurology (drugs and medicines)

Mesh:

Substances:

Year:  2018        PMID: 30567237      PMCID: PMC6301458          DOI: 10.1136/bcr-2018-226664

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease.

Authors:  M L Jacquemont; D Campion; V Hahn; C Tallaksen; T Frebourg; A Brice; A Durr
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

2.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation.

Authors:  M Anheim; D Hannequin; C Boulay; C Martin; D Campion; C Tranchant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

4.  Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade of life.

Authors:  John S K Kauwe; Jun Wang; Sumi Chakraverty; Alison M Goate; Andres F Henao-Martinez
Journal:  Neurosci Lett       Date:  2008-04-15       Impact factor: 3.046

5.  A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia.

Authors:  Silvia Testi; Silvio Peluso; Gian Maria Fabrizi; Antonella Antenora; Cinzia Valeria Russo; Sabina Pappatà; Alessandro Padovani; Moreno Ferrarini; Alessandro Filla
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease.

Authors:  M Melanson; J Nalbantoglu; S Berkovic; C Melmed; E Andermann; L J Roberts; S Carpenter; G J Snipes; F Andermann
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

7.  A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.

Authors:  R Crook; A Verkkoniemi; J Perez-Tur; N Mehta; M Baker; H Houlden; M Farrer; M Hutton; S Lincoln; J Hardy; K Gwinn; M Somer; A Paetau; H Kalimo; R Ylikoski; M Pöyhönen; S Kucera; M Haltia
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

8.  A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years.

Authors:  T Wisniewski; W K Dowjat; J D Buxbaum; O Khorkova; S Efthimiopoulos; J Kulczycki; W Lojkowska; J Wegiel; H M Wisniewski; B Frangione
Journal:  Neuroreport       Date:  1998-01-26       Impact factor: 1.837

9.  A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations.

Authors:  Wieslaw K Dowjat; Izabela Kuchna; Thomas Wisniewski; Jerzy Wegiel
Journal:  J Alzheimers Dis       Date:  2004-02       Impact factor: 4.472

10.  Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques.

Authors:  Claire E Shepherd; Gillian C Gregory; James C Vickers; William S Brooks; John B J Kwok; Peter R Schofield; Jillian J Kril; Glenda M Halliday
Journal:  Neurobiol Dis       Date:  2004-02       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.